Dr. Eli Ipp is Professor of Medicine at the UCLA School of Medicine, Head of the Section of Diabetes and Metabolism at Harbor-UCLA Medical Center and Associate Director of its General Clinical Research Center. Eli is a graduate of the University of the Witwatersrand in Johannesburg, South Africa and completed his training at the Sheba Medical Center in Israel and the University of Texas, Southwestern Medical School. Board certified in internal medicine and endocrinology, Eli has held faculty positions at the Hebrew University and the University of Chicago. His major areas of research interest are islet physiology and its relationship to the pathogenesis of diabetes and hypoglycemia.

In the past three years, Dr. Ipp has received grant/research support from Pfizer, Inc., R.W. Johnson, and Novo-Nordisk. He has served as a consultant for Novo-Nordisk, SmithKline Beecham Pharmaceutical and Hoechst Marion Roussel. Dr Ipp has also served on the Speakers' Bureau for Novo-Nordisk.